Huang, Ching-ShuiChing-ShuiHuangTsai, Ming-LinMing-LinTsaiTZU-PIN LUTu, Chao-ChiangChao-ChiangTuLiu, Chih-YiChih-YiLiuHuang, Chi-JungChi-JungHuangHo, Yuan-SoonYuan-SoonHoTu, Shih-HsinShih-HsinTuChuang, Eric YEric YChuangTseng, Ling-MingLing-MingTsengHuang, Chi-ChengChi-ChengHuang2023-03-212023-03-212022-100929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/629503Previously we had identified concurrent genes, which highlighted the interplay between copy number variation (CNV) and differential gene expression (GE) for Han Chinese breast cancers. The merit of the approach is to discovery biomarkers not identifiable by conventional GE only data, for which phenotype-correlation or gene variability is the criteria of gene selection.enBreast cancer; Consensus; Extended concurrent genes signature; Leading edge analysis; Partial least square regression[SDGs]SDG3The extended concurrent genes signature for disease-free survival in breast cancerjournal article10.1016/j.jfma.2022.01.022351812012-s2.0-85124663524WOS:000860557400009https://api.elsevier.com/content/abstract/scopus_id/85124663524